Search - tctmd.com

Displaying 141 - 160 of 287

Sort: Relevancy | Date

Presentation NY Valves 2025

Clinical Trials Update: Real-World Tricuspid TEER Registries

Presenter: Jörg Hausleiter

June 25, 2025

Presentation NY Valves 2025

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

Presenter: Erwan Donal

June 25, 2025

Presentation NY Valves 2025

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Presenter: Tamari Lomaia

June 25, 2025

Presentation NY Valves 2025

Screening for Tricuspid Valve Interventions: Using All the Tools in the Toolbox!

Presenter: Joao L. Cavalcante

June 25, 2025

News Conference News NY Valves 2024

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

Todd Neale

June 07, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Anatomy for Tricuspid Interventions: "Live" from the OR

Presenter: Isaac George

June 07, 2024

Presentation NY Valves 2024

What’s Next? Managing the Disease and Advanced Training

Presenter: Charles J. Davidson

June 07, 2024

Presentation NY Valves 2024

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Presenter: Georg Nickenig

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Presenter: Brian K. Whisenant

June 07, 2024

Presentation NY Valves 2024

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

Presenter: Susheel K. Kodali

June 07, 2024

Presentation NY Valves 2024

The Compelling Case for Transcatheter Tricuspid Therapies

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

Presenter: Jörg Hausleiter

June 07, 2024

Presentation NY Valves 2024

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Presenter: Eric Horlick

June 07, 2024

Presentation NY Valves 2024

Case-in-Box - Cardiovalve

Presenter: Christian Frerker

June 07, 2024

Presentation NY Valves 2024

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

Presenter: D. Scott Lim

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Presenter: Azeem Latib

June 07, 2024

Presentation NY Valves 2024

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Presenter: Rishi Puri

June 07, 2024

Presentation NY Valves 2024

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

Presenter: Christopher Liu

June 07, 2024

Advertisement

Clinical Trials Update: Real-World Tricuspid TEER Registries

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

Outcomes of Patients 75 Years and Older With Bicuspid vs Tricuspid Aortic Valves Undergoing TAVR

Screening for Tricuspid Valve Interventions: Using All the Tools in the Toolbox!

T-TEER for Tricuspid Regurgitation Induces Reverse Remodeling, Works in Tricky Anatomies

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Anatomy for Tricuspid Interventions: "Live" from the OR

What’s Next? Managing the Disease and Advanced Training

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

The Compelling Case for Transcatheter Tricuspid Therapies

Case-in-Box - TOPAZ Transcatheter Tricuspid Valve Replacement

What Is the Future of Percutaneous Tricuspid Valve Procedures?

Case-in-Box - Cardiovalve

Tricuspid Valve Anatomy (and Pathology): Who Is a Candidate for Transcatheter Tricuspid Valve Edge-to-Edge Repair?

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Anywhere But There: CIED Options (PPM/ICD) in Patients Following Tricuspid Valve Intervention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content